Abstract:BACKGROUND: The objective of this study was to investigate the role and molecular mechanism of cyclin-dependent kinase 5 (CDK5) in regulating the growth of tongue squamous cell carcinoma (TSCC).METHODS: The authors used multiple methods to detect the levels of CDK5 expression in samples of TSCC and to explore the relation between CDK5 expression and various clinicopathologic factors. In vivo and in vitro cell experiments were performed to detect the proliferation, invasion, and migration of TSCC cells with CDK5 knockdown or overexpression. These studies verified that CDK5 regulates the occurrence and development of TSCC cells through the microRNA 513c-5p/cell division cycle 25B pathway.RESULTS: An elevated level of CDK5 expression in TSCC tissues was identified as an independent risk factor affecting TSCC growth and patient prognosis. Patients who had TSCC with low levels of CDK5 expression had a higher survival rate than those with high levels. Knockdown of CDK5 reduced the proliferation, migration, and invasion of TSCC cells both in vitro and in vivo. In addition, the authors observed that CDK5 regulated the growth of TSCC through the microRNA 513c-5p/cell division cycle C25B pathway.CONCLUSIONS: CDK5 functions as an oncogene in TSCC and might serve as a molecular marker for use in the diagnosis and treatment of TSCC.LAY SUMMARY: Tongue squamous cell carcinoma (TSCC) is 1 of the most common malignant tumors of the head and neck, and the survival rate of patients with tongue cancer has been very low. Therefore, it is important to study the molecular mechanism of TSCC progression to identify biomarkers that can be used to improve its clinical diagnosis and treatment. Cyclin-dependent kinase 5 (CDK5) is an atypical member of the cyclin-dependent kinase family and is involved in regulating the cell cycle. Changes in the cell cycle are of great significance for the occurrence and development of tumor cells; and, in recent years, increasing evidence has suggested that CDK5 exists in a disordered state in cancer cells. In this study, the authors demonstrate that CDK5 functions as an oncogene in TSCC and might serve as a molecular marker for use in the diagnosis and treatment of TSCC.

CCN5 inhibits proliferation and promotes apoptosis of oral squamous cell carcinoma cells

CDK5RAP2 is a Wnt target gene and promotes stemness and progression of oral squamous cell carcinoma

C1QTNF6 Promotes Oral Squamous Cell Carcinoma by Enhancing Proliferation and Inhibiting Apoptosis

<i>Dlx5</i> promotes cancer progression through regulation of <i>CCND1</i> in oral squamous cell carcinoma (OSCC)

SIRT5 functions as a tumor suppressor in renal cell carcinoma by reversing the Warburg effect

Knockdown of LRP5 Promotes Proliferation and Invasion of Tongue Squamous Cell Carcinoma Through Compensatory Activation of Akt Signaling

Regulation of proliferation and cell cycle by protein regulator of cytokinesis 1 in oral squamous cell carcinoma

LINC01355 Contributes to Malignant Phenotype of Oral Squamous Cell Carcinoma and Cytotoxic T Cell Infiltration Via Activating Notch Signaling Pathway

CMTM5 Exhibits Tumor Suppressor Activity Through Promoter Methylation in Oral Squamous Cell Carcinoma

Cyclin‐dependent kinase 5 promotes the growth of tongue squamous cell carcinoma through the microRNA 513c‐5p/cell division cycle 25B pathway and is associated with a poor prognosis

CSN5 Controls the Growth of Osteosarcoma Via Modulating the EGFR/PI3K/Akt Axis.

CCL21/CCR7 interaction promotes EMT and enhances the stemness of OSCC via a JAK2/STAT3 signaling pathway

Knockdown of Stanniocalcin-1 inhibits growth and glycolysis in oral squamous cell carcinoma cells

Silencing of LncRNA SNHG16 Downregulates Cyclin D1 (CCND1) to Abrogate Malignant Phenotypes in Oral Squamous Cell Carcinoma (OSCC) Through Upregulating Mir-17-5p

Increased expression of lncRNA CASC9 promotes tumor progression by suppressing autophagy-mediated cell apoptosis via the AKT/mTOR pathway in oral squamous cell carcinoma

CCNI2 plays a promoting role in the progression of colorectal cancer

LINC00525 Promotes Tumour Growth and Epithelial-Mesenchymal Transition As an Oncogene in Oral Squamous Cell Carcinoma.

Knockdown of circXPO1 inhibits the development of oral squamous cell carcinoma cells

OSR1 suppresses oral squamous cell carcinoma proliferation and migration via the AXIN2/β‐catenin pathway

CDK1 and CCNA2 play important roles in oral squamous cell carcinoma

CLSPN Actives Wnt/β-catenin Signaling to Facilitate Glycolysis and Cell Proliferation in Oral Squamous Cell Carcinoma.